Literature DB >> 18445595

G13-dependent activation of MAPK by thyrotropin.

Thomas R H Büch1, Heike Biebermann, Hermann Kalwa, Olaf Pinkenburg, Denise Hager, Holger Barth, Klaus Aktories, Andreas Breit, Thomas Gudermann.   

Abstract

Stimulation of the thyrotropin receptor (TSHR) activates G proteins of all four subfamilies (G(s), G(i/o), G(q/11), and G(12/13)). Whereas G(s)/cAMP-dependent cellular responses upon TSHR stimulation are well established, other signaling pathways are less characterized. We evaluated TSH-elicited cellular responses in human follicular thyroid carcinoma cells stably expressing the TSHR and in primary, nonneoplastic human thyrocytes. In these cellular models, stimulation with TSH caused activation of p44/42 MAPK and subsequent induction of c-Fos. MAPK stimulation occurred independently of G(s), G(i/o), and G(q/11) signaling. Dominant negative constructs of G(12) or G(13) as well as shRNA-mediated suppression of Galpha(12) or Galpha(13) revealed that MAPK activation was dependent on G(13) but not on G(12) signaling. Furthermore, G(13)-dependent transactivation of the epidermal growth factor receptor was necessary for MAPK activation in follicular carcinoma cells, whereas EGFR was not involved in MAPK activation in nonneoplastic primary thyrocytes. The use of bacterial inhibitors of monomeric GTPases revealed that MAPK activation proceeded independently of Rho proteins but was clostridial toxin B-sensitive, suggesting involvement of Cdc42 or Rac. Thus, our data shed new light on cAMP-independent TSHR signaling and identify the first G(13)-dependent TSHR signaling pathway in human thyrocytes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18445595     DOI: 10.1074/jbc.M800211200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  FOXO1 controls thyroid cell proliferation in response to TSH and IGF-I and is involved in thyroid tumorigenesis.

Authors:  Miguel A Zaballos; Pilar Santisteban
Journal:  Mol Endocrinol       Date:  2012-11-16

2.  Neutral antibodies to the TSH receptor are present in Graves' disease and regulate selective signaling cascades.

Authors:  Syed A Morshed; Takao Ando; Rauf Latif; Terry F Davies
Journal:  Endocrinology       Date:  2010-09-15       Impact factor: 4.736

3.  Human TSH receptor ligands as pharmacological probes with potential clinical application.

Authors:  Susanne Neumann; Bruce M Raaka; Marvin C Gershengorn
Journal:  Expert Rev Endocrinol Metab       Date:  2009-11-01

4.  β-Arrestin-1 mediates thyrotropin-enhanced osteoblast differentiation.

Authors:  Alisa Boutin; Elena Eliseeva; Marvin C Gershengorn; Susanne Neumann
Journal:  FASEB J       Date:  2014-04-10       Impact factor: 5.191

5.  Leucine-rich repeat-containing G-protein coupled receptor 5/GPR49 activates G12/13-Rho GTPase pathway.

Authors:  Mi So Kwon; Bi-oh Park; Ho Min Kim; Sunhong Kim
Journal:  Mol Cells       Date:  2013-08-01       Impact factor: 5.034

Review 6.  Novel insights on thyroid-stimulating hormone receptor signal transduction.

Authors:  Gunnar Kleinau; Susanne Neumann; Annette Grüters; Heiko Krude; Heike Biebermann
Journal:  Endocr Rev       Date:  2013-05-03       Impact factor: 19.871

7.  Insights into Basal Signaling Regulation, Oligomerization, and Structural Organization of the Human G-Protein Coupled Receptor 83.

Authors:  Anne Müller; Julia Catherine Berkmann; Patrick Scheerer; Heike Biebermann; Gunnar Kleinau
Journal:  PLoS One       Date:  2016-12-09       Impact factor: 3.240

Review 8.  Structural-Functional Features of the Thyrotropin Receptor: A Class A G-Protein-Coupled Receptor at Work.

Authors:  Gunnar Kleinau; Catherine L Worth; Annika Kreuchwig; Heike Biebermann; Patrick Marcinkowski; Patrick Scheerer; Gerd Krause
Journal:  Front Endocrinol (Lausanne)       Date:  2017-04-24       Impact factor: 5.555

9.  CD40 Expression in Fibrocytes Is Induced by TSH: Potential Synergistic Immune Activation.

Authors:  Tünde Mester; Nupur Raychaudhuri; Erin F Gillespie; Hong Chen; Terry J Smith; Raymond S Douglas
Journal:  PLoS One       Date:  2016-09-15       Impact factor: 3.240

Review 10.  Insulin-Like Growth Factor Pathway and the Thyroid.

Authors:  Terry J Smith
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-04       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.